Elevai Labs, Inc. (NASDAQ:ELAB) Sees Significant Growth in Short Interest

Elevai Labs, Inc. (NASDAQ:ELAB) was the recipient of a significant growth in short interest in the month of March. As of March 31st, there was short interest totalling 78,300 shares, a growth of 251.1% from the March 15th total of 22,300 shares. Based on an average daily volume of 345,400 shares, the short-interest ratio is presently 0.2 days. Currently, 2.6% of the company’s stock are sold short.

Elevai Labs Stock Down 11.3 %

Elevai Labs stock traded down $0.33 during midday trading on Wednesday, reaching $2.58. The stock had a trading volume of 1,326,159 shares, compared to its average volume of 196,568. The company has a fifty day moving average price of $6.77 and a two-hundred day moving average price of $33.66. The company has a market capitalization of $1.82 million, a P/E ratio of -0.04 and a beta of -1.23. The company has a current ratio of 3.86, a quick ratio of 3.40 and a debt-to-equity ratio of 0.06. Elevai Labs has a 12 month low of $2.28 and a 12 month high of $1,064.00.

Elevai Labs Company Profile

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.